Cell & Gene Therapy Manufacturing Services Market Trends and Overview

The market size of Cell & Gene Therapy Manufacturing Services was valued at USD 16.92 billion in 2022. It is projected to reach USD 30.86 billion by 2030, with a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2023 to 2030.

Cell and gene therapy manufacturing services have witnessed significant growth in recent years, driven by advancements in medical research and the increasing demand for personalized medicine. This market segment plays a crucial role in the development and production of innovative therapies that harness the potential of cells and genes to treat various diseases.

The projected growth in the market size reflects the rising adoption of cell and gene therapies across the healthcare industry. These therapies offer promising solutions for previously untreatable conditions, such as genetic disorders, cancer, and autoimmune diseases. As a result, pharmaceutical and biotechnology companies are investing heavily in the development and commercialization of these advanced therapies.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1187

Furthermore, the increasing prevalence of chronic diseases and the aging population contribute to the expanding demand for cell and gene therapy manufacturing services. With the growing need for effective and personalized treatments, the market is expected to witness sustained growth in the coming years.

In conclusion, the Cell & Gene Therapy Manufacturing Services Market is poised for substantial growth, with a projected value of USD 30.86 billion by 2030. The industry's expansion is driven by advancements in medical research, the rising adoption of cell and gene therapies, and the increasing demand for personalized medicine. As the market continues to evolve, it presents significant opportunities for pharmaceutical and biotechnology companies to develop innovative therapies that can revolutionize the treatment of various diseases.

KEY MARKET SEGMENTATION:

By Therapy Type

• Gene Therapy Manufacturing
• Cell Therapy Manufacturing
  • Non-Stem Cell Therapy
  • Stem Cell Therapy

By Scale Type

• Commercial Scale Manufacturing
• Pre-commercial/ R&D Scale Manufacturing

By Mode type

• In-house Manufacturing
• Contract Manufacturing

By Workflow type

• Cell Processing
• Fill & Finish Operations
• Vector Production
• Analytical And Quality Testing
• Cell Banking
• Process Development
• Raw Material Testing
• Others

Major Players Listed in the Report are as Follows:

Merck KGaA, Thermo Fisher Scientific, Catalent Inc., Lonza, Takara Bio Inc., Wuxi Advanced Therapies, F. Hoffmann-La Roche Ltd, Samsung Biologics, Bluebird Bio Inc., Novartis AG, Boehringer Ingelheim, Hitachi Chemical Co., Ltd., Miltenyi Biotec, Cellular Therapeutics.

Other Reports You May Like:

Oxytocic Pharmaceuticals Market @ https://www.linkedin.com/pulse/oxytocic-pharmaceuticals-market-manufacturers-regions-rohit-deshmukh/

Surgical Robots Market @ https://www.linkedin.com/pulse/surgical-robots-market-size-growth-industry-share-trends-deshmukh/

4D Printing in Healthcare Market @ https://www.linkedin.com/pulse/4d-printing-healthcare-market-size-share-industry-growth-deshmukh/

Legal Marijuana Market @ https://www.linkedin.com/pulse/legal-marijuana-industry-market-challenges-business-study-deshmukh

Urinary Incontinence Treatment Devices Market @ https://www.linkedin.com/pulse/urinary-incontinence-treatment-devices-market-study-rohit-deshmukh/

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com